AgomAb Therapeutics NV’s USD 74 Million Series B Financing round

Deloitte Legal assisted AgomAb Therapeutics NV on the deal.AgomAb Therapeutics NV completed the raise of a USD 74 million Series B financing round to fund a…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now